APA (7th ed.) Citation

X, Z., Q, Y., Y, Z., X, Z., Y, H., & Q, Y. (2026). Saikosaponin-d attenuates postpartum estrogen withdrawal-induced depressive symptoms by modulating glucocorticoid metabolism and inhibiting hippocampal NLRP3 inflammatory vesicle activation. Metabolic brain disease, 41(1), . https://doi.org/10.1007/s11011-026-01841-9

Chicago Style (17th ed.) Citation

X, Zhai, Yang Q, Zhao Y, Zeng X, He Y, and You Q. "Saikosaponin-d Attenuates Postpartum Estrogen Withdrawal-induced Depressive Symptoms by Modulating Glucocorticoid Metabolism and Inhibiting Hippocampal NLRP3 Inflammatory Vesicle Activation." Metabolic Brain Disease 41, no. 1 (2026). https://doi.org/10.1007/s11011-026-01841-9.

MLA (9th ed.) Citation

X, Zhai, et al. "Saikosaponin-d Attenuates Postpartum Estrogen Withdrawal-induced Depressive Symptoms by Modulating Glucocorticoid Metabolism and Inhibiting Hippocampal NLRP3 Inflammatory Vesicle Activation." Metabolic Brain Disease, vol. 41, no. 1, 2026, https://doi.org/10.1007/s11011-026-01841-9.